News Industry News NaviGate Cardiac Structures Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient to correct “torrential” tricuspid regurgitation (TR) August 30, 2017
News Daily News Focused Update to Valve Guidelines Tackles Intermediate-Risk TAVR, Anticoagulation for A-fib Todd Neale March 15, 2017
News Daily News NeuroARC Proposes New Standards for Assessing Neurologic Damage in CV Clinical Trials Caitlin E. Cox February 07, 2017